1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
601.59%
Cash & equivalents growing 601.59% while Healthcare shows decline of -4.77%. Warren Buffett would see this as a competitive advantage in maintaining liquidity while peers face cash constraints.
-5.55%
Short-term investments yoy growth below half the Healthcare median of 0.00%. Jim Chanos would question if the firm lacks surplus cash or is facing liquidity stress.
-2.61%
Cash + STI yoy growth ≥ 1.5x the Healthcare median of -1.21%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.
73.46%
Receivables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a serious red flag in ballooning receivables.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.28%
Current assets growth ≥ 1.5x the Healthcare median of -0.83%. Joel Greenblatt sees a potential liquidity edge if well allocated.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.28%
Below half the Healthcare median of 0.00%. Jim Chanos might see potential stagnation or distress vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
258.47%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.
258.47%
Below half Healthcare median of -0.52%. Joel Greenblatt sees more conservative short-term leverage than peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
258.47%
Below half Healthcare median of -0.01%. Joel Greenblatt sees a much lower liability expansion vs. peers.
-2.23%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.
-3.82%
≥ 1.5x Healthcare median of -0.71%. Joel Greenblatt sees stronger retained profit growth vs. peers.
No Data
No Data available this quarter, please select a different quarter.
-2.23%
Above 1.5x Healthcare median of 0.00%. Jim Chanos sees a potential red flag for complicated equity transactions.
-4.94%
Below half Healthcare median of 0.00%. Jim Chanos suspects slower net worth growth or losses vs. peers.
-2.28%
Below half Healthcare median of 0.00%. Jim Chanos suspects a major slowdown or distress.
-5.55%
Below half Healthcare median of 0.00%. Jim Chanos sees potential underinvestment or forced liquidation vs. peers.
No Data
No Data available this quarter, please select a different quarter.
-601.59%
Below half of Healthcare median 3.52%. Joel Greenblatt sees stronger deleveraging or cash accumulation vs. peers.
